SS
PBYI icon

SBI Securities’s Puma Biotechnology PBYI Stock Holding History

SBI Securities’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454 Hold
56
– – ﹤0.01% 3061
2026
Q1 		$358 Hold
56
– – ﹤0.01% 3015
2025
Q4 		$333 Hold
56
– – ﹤0.01% 3026
2025
Q3 		$297 Hold
56
– – ﹤0.01% 3196
2025
Q2 		$192 Hold
56
– – ﹤0.01% 3323
2025
Q1 		$166 Hold
56
– – ﹤0.01% 3285
2024
Q4 		$171 Buy
+56
New +$163 ﹤0.01% 3296

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's PBYI Position: Q2 2026 in Review

SBI Securities held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 56 shares worth $454. The position accounts for ﹤0.01% of the portfolio, ranked #3061.

SBI Securities first reported a position in PBYI in Q4 2024 and has held it in 7 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • SBI Securities held 56 shares of Puma Biotechnology worth $454 as of Q2 2026.
  • SBI Securities left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3061 holding.
  • SBI Securities first reported a position in Puma Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.